Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
Patricia Maiso, Pedro Mogollón, Enrique M. Ocio, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2542-2542
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Emerging tumor-on-chips with electrochemical biosensors
Lanjie Lei, Biao Ma, Chengtao Xu, et al.
TrAC Trends in Analytical Chemistry (2022) Vol. 153, pp. 116640-116640
Closed Access | Times Cited: 49
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy
Brian M. Russell, David Avigan
International Journal of Hematology (2023) Vol. 117, Iss. 5, pp. 652-659
Open Access | Times Cited: 17
Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma
Sebastian A. Dziadowicz, Lei Wang, Halima Akhter, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 927-927
Open Access | Times Cited: 20
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells
Marco Cippitelli, Helena Stabile, Andrea Kosta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1823-1823
Open Access | Times Cited: 13
A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
Hayley M. Sabol, Cody Ashby, Manish Adhikari, et al.
Haematologica (2024)
Open Access | Times Cited: 4
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma
Lorenzo Cuollo, Samuele Di Cristofano, Annamaria Sandomenico, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109814-109814
Open Access | Times Cited: 4
Multiple Myeloma Insights from Single-Cell Analysis: Clonal Evolution, the Microenvironment, Therapy Evasion, and Clinical Implications
Sihong Li, Jiahui Liu, Madeline Peyton, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 653-653
Open Access
Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications
Mengping Chen, Jinxing Jiang, Jian Hou
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma
Ashley Del Dosso, Elizabeth Tadevosyan, James R. Berenson
Oncotarget (2024) Vol. 15, Iss. 1, pp. 65-75
Open Access | Times Cited: 3
Co-culture of multiple myeloma cell lines and bone marrow mesenchymal stem cells in a 3D microgel environment
María Inmaculada García-Briega, Júlia Plá-Salom, Sandra Clara‐Trujillo, et al.
Biomaterials Advances (2025) Vol. 172, pp. 214243-214243
Open Access
Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome
Sylwia Popek-Marciniec, Wojciech Styk, Sylwia Chocholska, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
Sina Kamrani, Reza Naseramini, Pouria Khani, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Therapeutic Target Discovery for Multiple Myeloma: Identifying Druggable Genes via Mendelian Randomization
Shijun Jiang, Fengjuan Fan, Qun Li, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 885-885
Open Access
Myeloma mesenchymal stem cells’ bioenergetics afford a novel selective therapeutic target
Oded Komemi, Elina Orbuch, Osnat Jarchowsky-Dolberg, et al.
Oncogenesis (2025) Vol. 14, Iss. 1
Open Access
Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disorders
Mohamed J. Saadh, Ahmed S. Hussein, Alireza Bayani, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Transcriptional Remodeling of the Stromal and Endothelial Microenvironment in MGUS to Multiple Myeloma Progression
Itziar Cenzano, Miguel Cócera, Azari Bantan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 3
Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy
Remya Nair, Pulkit Gupta, Mala Shanmugam
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms
Hao Guo, Jingyi Yang, Haoran Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
Jingya Wang, Ziyi Peng, Jing Guo, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 10, pp. 1384-1399
Closed Access | Times Cited: 6
The Role of the Gut Microbiome in Hematological Cancers
Najihah Hussein, Reena Rajasuriar, Asif M. Khan, et al.
Molecular Cancer Research (2023) Vol. 22, Iss. 1, pp. 7-20
Closed Access | Times Cited: 4
Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
Lei Wang, Weijun Yi, Li Ma, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5148-5148
Open Access | Times Cited: 4
Virtual screening, pharmacokinetics & MD simulation study of active phytoconstituents of Ficus Carica Linn. against PPAR-γ in diabetes mellitus
Shridhar Deshpande N, Prarambh S. R. Dwivedi, B. C. Revanasiddappa
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-17
Closed Access | Times Cited: 4
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again
Federica Plano, Anna Maria Corsale, Emilia Gigliotta, et al.
Hematology Reports (2023) Vol. 15, Iss. 1, pp. 23-49
Open Access | Times Cited: 3
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease
Martin Berg Johansen, Mette Bøegh Levring, Kasper Stokbro, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5585-5585
Open Access | Times Cited: 3
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
Andrea Kosta, Abdelilah Mekhloufi, Lorenzo Lucantonio, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top